Please login to the form below

Not currently logged in
Email:
Password:

RedHill Biopharma

This page shows the latest RedHill Biopharma news and features for those working in and with pharma, biotech and healthcare.

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

RedHill Biopharma has announced that its experimental sphingosine kinase-2 (SK2) opaganib demonstrated potent inhibition of SARS-CoV-2 in an in vitro clinical test. ... benefit COVID-19 patients by inhibiting the key drivers of disease progression -

Latest news

  • RedHill Biopharma advances phase 2/3 COVID-19 programme RedHill Biopharma advances phase 2/3 COVID-19 programme

    Submits clinical trial applications in Mexico and Brazil. Israeli biopharmaceutical company RedHill Biopharma has announced that it has accelerated its COVID-19 programme with the submission of new clinical trial applications ... Last month, RedHill

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...